香港股市 已收市

Merck & Co., Inc. (MRK)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
129.49-1.60 (-1.22%)
收市:04:00PM EDT
129.49 0.00 (0.00%)
收市後: 07:59PM EDT

Merck & Co., Inc.

126 East Lincoln Avenue
Rahway, NJ 07065
United States
908 740 4000
https://www.merck.com

版塊Healthcare
行業Drug Manufacturers—General
全職員工70,000

高階主管

名稱頭銜支付行使價出生年份
Mr. Robert M. Davis J.D.Chairman, President & CEO5.57M8.44M1967
Ms. Caroline LitchfieldExecutive VP & CFO3.09M1969
Mr. Richard R. DeLuca Jr.Executive VP & President of Merck Animal Health2.4M8.03M1963
Mr. Sanat ChattopadhyayExecutive VP & President of Merck Manufacturing Division2.49M12.49M1960
Dr. Dean Y. Li M.D., Ph.D.Executive VP & President of Merck Research Laboratories3.61M1963
Mr. Dalton E. Smart IIISenior VP of Finance, Principal Accounting Officer & Global Controller1967
Mr. David Michael WilliamsExecutive VP and Chief Information & Digital Officer1969
Mr. Peter DannenbaumVice President of Investor Relations
Ms. Jennifer L. ZacharyExecutive VP & General Counsel2.73M3.46M1978
Lisa LeCointe-CephasSenior VP and Chief Ethics & Compliance Officer1982
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

公司管治

截至 2024年5月1日 止,Merck & Co., Inc. 的 ISS 管治質素評分為 4。 Pillar 分數正在審核中:7;董事會:5;股東權利:3;現金賠償:5。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。